Microsoft Word - tRNA-Cyt c Text.docx

The intrinsic apoptosis pathway occurs through the release of mitochondrial cytochrome c to the cytosol, where it promotes activation of the caspase family of proteases. The observation that tRNA binds to cytochrome c revealed a previously unexpected mode of apoptotic regulation. However, the molecular characteristics of this interaction, and its impact on each interaction partner, are not well understood. Using a novel fluorescence assay, we show here that cytochrome c binds to tRNA with an affinity comparable to other tRNAprotein binding interactions and with a molecular ratio of ~3:1. Cytochrome c recognizes the tertiary structural features of tRNA, particularly in the core region. This binding is independent of the charging state of tRNA, but is regulated by the redox state of cytochrome c. Compared to reduced cytochrome c, oxidized cytochrome c binds to tRNA with a weaker affinity, which correlates with its stronger pro-apoptotic activity. tRNA binding both facilitates cytochrome c reduction and inhibits the peroxidase activity of cytochrome c, which is involved in its release from mitochondria. Together, these findings provide new insights into the cytochrome ctRNA interaction and apoptotic regulation. INTRODUCTION Cytochrome c is a heme-containing protein that normally resides in the mitochondrial intermembrane space. It carries electrons from cytochrome c reductase (the cytochrome b-c1 complex) to cytochrome c oxidase as part of the electron transport chain that builds an electrochemical gradient driving the synthesis of ATP. This function of cytochrome c may be conserved over one and a half billion years of eukaryotic evolution (1). In vertebrate cells cytochrome c has taken on an additional role as a critical inducer of apoptosis, or programmed cell death, which eliminates unwanted or harmful cells (1,2). Apoptosis can occur through either of two major apoptotic pathways. The intrinsic apoptotic pathway is activated by intracellular stimuli such as DNA damage, oncogene activation, and developmental information. The extrinsic apoptotic pathway responds to extracellular stimuli via cell surface death receptors. The intrinsic pathway is evolutionarily more conserved than the extrinsic pathway, and can be activated by the extrinsic pathway to amplify the apoptotic response. The defining event in the intrinsic pathway is the release of cytochrome c from mitochondria into the cytosol, where it binds to Apaf-1 (apoptotic protease activating factor-1), facilitating the assembly of the oligomeric apoptosome (3-5). The apoptosome recruits and activates the initiator caspase, caspase-9 (6). Caspase-9 subsequently activates executioner caspases, leading to the cleavage of a large http://www.jbc.org/cgi/doi/10.1074/jbc.M115.697789 The latest version is at JBC Papers in Press. Published on March 9, 2016 as Manuscript M115.697789 Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 2 number of cellular proteins and eventually cellular death (7-9). The activation of caspases by cytochrome c is intricately regulated. Release of cytochrome c is facilitated by the oxidation of cardiolipins, which anchor cytochrome c on the inner mitochondrial membrane, and by mitochondrial outer membrane permeabilization (MOMP), a process that is regulated by members of the B-cell lymphoma protein-2 (Bcl2) family (1). In the cytoplasm, the ability of cytochrome c to activate caspases is modulated by its redox state, with the oxidized form showing a much more potent activity compared to the reduced form (10). Effective assembly of the apoptosome requires, in addition to cytochrome c and ATP, the proteins HSP70, cellular apoptosis susceptibility protein (CAS), and the PHAPI tumor suppressor (2,3,6). Apoptosome formation is inhibited by the oncoprotein prothymosin-α (11,12). Nucleic acid, specifically transfer RNA (tRNA), is also implicated in the regulation of cytochrome cmediated caspase activation (13). tRNA is responsible for the interpretation of nucleic acid sequences as amino acid sequences during protein synthesis in all known forms of life (14,15). Mature tRNAs are 73 to 93 ribonucleotides in length and fold into a cloverleaf secondary and L-shaped tertiary structure. tRNA is "charged" by conjugation with an amino acid at the conserved 3'-CCA sequence, which resides at one end of the L-shaped structure. Opposite this end, a three-nucleotide anticodon sequence pairs with a specific mRNA codon, and enables the translation of the codon into a specific amino acid. tRNA interacts with a number of proteins and other RNAs during its maturation, transport, aminoacylation (“charging”), and movement in and out of the ribosome. It also has a high degree of functional versatility in addition to protein synthesis. Non-canonical functions of tRNA include priming reverse transcription of specific viral genomes (16) and stimulating gene expression in response to amino acid deprivation (17). We previously showed that tRNA binds directly to cytochrome c. The cytochrome c-tRNA binding prevents cytochrome c from interacting with Apaf-1 and activating apoptosis (13). This finding indicates that cytochrome c, in addition to supporting ATP production and to promoting apoptosis, is a tRNA-binding protein. However, while all cytosolic and mitochondrial tRNAs appear to participate in the interaction, the molecular basis remains unknown. Also mysterious is the effect of tRNA association on the redox state and enzymatic function of cytochrome c, which have been implicated in the release of cytochrome c and the activation of the caspase cascade. Here we further characterize the dynamics of the interaction between tRNA and cytochrome c, the influence of novel factors, and its consequences for each interaction partner. This study elucidates basic tenets of an ancient molecular interaction that has important consequences for apoptosis. EXPERIMENTAL PROCEDURES Reagents—A 78-nucleotide (nt) DNA oligo encoding the sequence of human initiator tRNA was synthesized by Integrated DNA Technologies (IDT; Coralville, IA). Cy3 was purchased from AAT Bioquest (Sunnyvale, CA), Cy5 from Lumiprobe (Hannover, Germany), and 2aminopurine (2AP) triphosphate from TriLink Biotech (San Diego, CA). The following reagents were purchased from Sigma-Aldrich (St. Louis, MO): bovine heart and yeast cytochrome c, total tRNA from baker's yeast (#R5636), ribosomal RNA, polyadenylic acid, NADH, NADPH, FAD, NaBH4, proflavine, ascorbic acid, and potassium ferricyanide. Onconase was provided by the Alfacell Corporation (Somerset, NJ). Fluorophore-labeled tRNAs—A fluorescent tRNA based on the tRNA sequence in E. coli was prepared by in vitro reconstitution. E. coli tRNA (etRNA, Fig. 1A) has been well characterized (18,19), and its crystal structure determined (20). A 5'-fragment encoding nucleotides G1 to C16 was chemically synthesized by IDT with the Cy3 fluorophore (Fig. 1B) attached to the 5' end (position 1) through a phosphodiester linkage. A 3'-fragment encoding G18 to A76 was synthesized by in vitro transcription, using T7 RNA polymerase, and was gel purified. The two fragments were joined by T4 RNA ligase I in a 3:1 molar ratio of the short vs. long fragment with a 70% yield (Fig. 1C). The ligated full-length tRNA (Cy3-etRNA) was separated from individual fragments by a denaturing gel, heated at 85 °C, by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 3 and re-annealed at 37 °C in the presence of Mg. Similar procedures were used to prepare a human elongator tRNA (htRNA) and a human tRNA (htRNA, Fig. 1A) that were labeled with Cy3 and Cy5, respectively, at the 5' end (Cy3-htRNA and Cy5-htRNA). The 2APlabeled E. coli tRNA (2AP-etRNA) was prepared by transcription of E. coli tRNA up to C75 and incorporating 2AP to position 76 using E. coli CCA adding enzyme and the triphosphate form of the fluorophore (21). The proflavinelabeled E. coli tRNA (Prf-etRNA) was prepared by inserting proflavine (Fig. 1B) to the D loop as described (21,22) (Fig. 1D). Briefly, the transcript of E. coli tRNA was modified by an insertion of U17, which was subsequently converted to D17 by Dus1p and reduced to the ureidopropanal group by NaBH4. The ureidopropanal group was then reacted with proflavine to form adduct with the fluorophore (Fig. 1D). All labeled tRNAs were separated from unlabeled species on a denaturing PAGE/7M urea gel. The full-length tRNAs were excited from gels, recovered by ethanol precipitation, and resuspended in the TE buffer. Binding affinity of cytochrome c with fluorescent tRNAs—Each fluorescent tRNA was titrated with bovine or yeast cytochrome c from 0.1 to 24.4 μM in the binding buffer (20 mM HEPES, pH 7.5, 35 mM KCl, 2.5 mM MgCl2, 0.5 mM EDTA, and 1 mM DTT) at room temperature, and the fluorescence emission was monitored. The peak intensity at 563 nm for Cy3 was corrected for the inner filter effect for each cytochrome c concentration, and the corrected data as a function of cytochrome c concentration were fit to a hyperbola equation to derive the Kd value. Stoichiometry of cytochrome c-tRNA interaction— The stoichiometry of cytochrome c binding to tRNA was determined by monitoring the fluorescence quenching of Cy3-etRNA and Cy5-htRNA on a PTI (photon Technology International) instrument model QM-4 as described (23). The binding was performed at room temperature in a buffer containing 20 μM labeled tRNA, 200 mM HEPES, pH 7.5, 50 mM NaCl, 5% sucrose, and 5 mM DTT. The bovine cytochrome c was titrated from 0 454 μM, with the cytochrome c/tRNA molar ratio ranging from 0 to 22.7. The Cy3-etRNA was excited at 550 nm, and the emission was monitored from 558 nm to 650 nm at room temperature. The Cy5htRNA was excited at 640 nm, and the emission was monitored from 655 nm to 720 nm. The emission peaks at 565 nm for Cy3-tRNA and at 662 nm for Cy5-tRNA were recorded and corrected for the inner filter effect, according to the formula, Fcorr = Fobs × antilog((Aexcitation + Aemission)/2), where Fcorr is the corrected fluorescent signal at the peak wavelength, and Fobs is the observed fluorescent signal at the peak wavelength. Surface plasmon resonance (SPR) assay—The association of various nucleic acids with cytochrome c was assessed by surface plasmon resonance using a Biacore 3000 system (GE Healthcare). Cytochrome c from bovine heart was immobilized on a CM5 sensor chip (Biacore) by amine coupling. Each nucleic acid was individually injected onto the immobilized cytochrome c. Binding interaction was performed in a low salt buffer (20 mM HEPES, 20 mM KCl, 2.5 mM MgCl2, 0.5 mM EDTA) or in a buffer with physiologic ionic strength (by adding KCl to 135 mM and NaCl to 10 mM to the low salt buffer). After each binding experiment, the chips were washed with a 0.5 M NaCl regeneration solution. CCA addition and tRNA charging reactions—The transcript of E. coli tRNA was synthesized up to C75 and was internally labeled in the transcription reaction containing a trace amount of [α-P]ATP. The addition of A76 to the gel purified labeled tRNA (0.1 μM) was catalyzed by human CCA adding enzyme (2 μM), in the presence or absence of oxidized bovine cytochrome c (15 μM). The assay was performed at 37 °C for 0-1 s on a KinTek RQF-3 instrument in the reaction buffer previously described (24-26). tRNA charging assay was performed using etRNA as the substrate and E. coli cysteinyltRNA synthetase (CysRS) as the enzyme, as previously described (27-29). The efficiency of charging was monitored using S-cysteine. After the reaction, tRNA was acid precipitated on filter pads, and the radioactivity of S-cysteine attached by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 4 to each tRNA was quantified by scintillation counting (30). Cytochrome c peroxidase activity—The peroxidase activity was determined by incubation of cytochrome c with enhanced chemilluminescence (ECL) solution and measuring light emission using an illuminometer. Cytochrome c oxidation and reduction—To generate the reduced protein, bulk cytochrome c was incubated with excess ascorbic acid and was then purified using a Sepharose column (GE healthcare). To generate the oxidized protein, bulk cytochrome c was incubated with potassium ferricyanide and purified similarly. The oxidation and reduction were confirmed by measuring absorbance at 550 nm and 560 nm as well as by colorimetric inspection of the purified protein. In cytochrome c oxidation and reduction assays, the redox state was monitored by continuous measurement of absorption at 550 nm. RESULTS A fluorescence-based assay for the cytochrome ctRNA interaction—We previously analyzed the cytochrome c-tRNA interaction using electrophoretic mobility shift assays (13). To provide an independent and quantitative evaluation of this interaction, we developed a fluorescence-based assay. Cytochrome c does not appear to strongly discriminate among various cytosolic and mitochondrial tRNA species (13), suggesting that prokaryotic tRNA may be just as capable of interacting with cytochrome c as eukaryotic tRNA. We used E. coli tRNA (etRNA) and tRNA (etRNA), and human elongator tRNA (htRNA) and tRNA (htRNA) as models (Fig. 1A). These tRNAs were labeled at the 5' end with either Cy3 (for etRNA and tRNA) or Cy5 (for htRNA), at 3'-end with 2-aminopurine (2AP) (for etRNA), or in the D-loop with proflavine (Prf) (for etRNA) (Fig. 1B). To obtain Cy3-etRNA, a chemically synthesized 5'-Cy3-attached fragment, encoding nucleotides G1 to C16, was joined with an in vitro-transcribed 3'-fragment, encoding nucleotides G18 to A76 (Fig. 1C) (26). Cy3htRNA and Cy5-htRNA were generated similarly. 2AP-etRNA was prepared by the addition of 2AP to 3'-end of an etRNA transcript containing nucleotides G1 to C75 (21). To produce Prf-etRNA, etRNA was modified by the insertion of a uridine at position 17, which was then converted to dihydrouridine and labeled with proflavine (22) (Fig. 1D). To assess whether the attachment of the fluorophores at the 5'-end affects the function of tRNA, we used etRNA as an example and compared charging of unlabeled and Cy3-labled etRNA to the 3'-end. Using S-cysteine as the substrate and E. coli cysteinyl-tRNA synthetase (CysRS) as the enzyme, we analyzed the attachment of S-cysteine to each tRNA over time. As shown in Fig. 2A, Cy3-etRNA was charged to ~85% of the unlabeled etRNA. This indicates that the labeling at the 5'-end does not interfere with charging. Interaction of these tRNAs with cytochrome c was measured by fluorescence quenching of the labeled tRNAs following cytochrome c addition (Fig. 2B). Quenching data were fit to a hyperbolic equation to obtain the Kd of the interaction, assuming a two-state (bound or unbound) model following correction for inner-filter effect and non-specific binding. Cytochrome c binds to tRNA with an affinity comparable to other tRNA-binding proteins and recognizes the tertiary structure of tRNA—We determined the affinity of bovine heart cytochrome c to Cy3-etRNA and observed a Kd in the range of 1-3.5 μM (Fig. 2, C and D, and Table 1). Importantly, this affinity was comparable to those of known tRNA-binding proteins, including aminoacyl-tRNA synthetase (aaRS) (1-3 μM) (27,31,32) and CCA-adding enzyme (tRNAnucleotidyltransferase) (0.8-3.3 μM) (25,26). To corroborate this finding, we also analyzed cytochrome c binding to Cy3-htRNA and 2APetRNA. Cytochrome c bound to these two tRNAs with affinities similar to etRNA (Kd = 4.8 ± 0.7 and 5.1 ± 0.9 μM, respectively; Table 1). Therefore, analysis of three unrelated tRNA species labeled with distinct fluorophores at different ends showed that cytochrome c bound to tRNA species with an affinity akin to those of other tRNA-binding proteins. Compared to Cy3-etRNA, cytochrome c bound to the D-loop-labeled Prf-etRNA with a by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 5 substantially reduced affinity (Kd of 9.6 ± 2.8 μM, Table 1). This might be due to proflavine in the Dloop interfering with cytochrome c binding directly or with folding of the tertiary structure of tRNA, both scenarios suggesting that the tRNA tertiary structure is required for high-affinity interaction with cytochrome c. We also used a Cy3-labeled fragment of etRNA encoding nucleotides 1 to 16 (Cy3-oligo), which resembled a microRNA or a tRNA-derived fragment and lacked the tertiary core structure (33). This fragment had greatly reduced affinity for cytochrome c (Kd > 30 μM, Table 1). To extend these analyses, we generated a mutant of etRNA, in which three nucleotides in the D loop (U20, U21, and A22) were deleted and the G48 nucleotide in the V-loop was changed to C (Fig. 2C, right). We have previously shown that the nucleotides in the D loop and G48, which forms base pair with G15, are critical for the integrity of the core (18,19,34,35). Thus, the resultant etRNA mutant likely has an incomplete tertiary structure. Indeed, this mutant bound to cytochrome c with a Kd of 5.5 ± 1.7 μM, which was a 5-fold increase relative to the Kd of 1.0 ± 0.3 μM of the wild-type tRNA determined in the same experiment (Fig. 2D). Together, these results support the notion that cytochrome c recognizes the tertiary structural features of tRNA, particularly in the core region. Surface plasmon resonance (SPR) analysis—To further independently assess the cytochrome ctRNA interaction, we performed an SPR analysis using a Biacore 3000 system. Bovine heart cytochrome c was immobilized on a CM5 sensor chip by amine coupling and tested for binding with mammalian total tRNA, ribosomal RNA (rRNA), a mixture of poly(A) RNAs, and a 78-nt DNA oligo corresponding to a human initiator tRNA. In a low salt buffer, only tRNA had distinct association and dissociation phases (Fig. 3, A-C). In a buffer with physiologic ionic strength, only tRNA binding was detectable above the baseline (Fig. 3D). These results again indicate that cytochrome c is a specific tRNA-binding protein. Cytochrome c associates with tRNA with a stoichiometric ratio of three cytochrome c molecules for each tRNA molecule—We next interrogated the binding stoichiometry between tRNA and cytochrome c. We titrated a fixed amount of Cy3-etRNA with increasing amounts of cytochrome c to shift the binding equilibrium in the direction of the bound complex. The titration produced a biphasic quenching of the Cy3etRNA fluorescence, with an initial steep phase followed by a second and much flatter phase (Fig. 3E). The two phases intercepted at a molar ratio of cytochrome c to tRNA at ~3.0, indicating that three cytochrome c molecules bind to one tRNA molecule. Further fluorescence quenching was also observed at higher protein stoichiometries, likely indicating nonspecific formation of higher order complexes. To confirm this binding stoichiometry, we tested Cy5-htRNA. Despite the use of a different fluorophore and a different tRNA, the titration maintained the same two phases that intersected at the cytochrome c/tRNA molar ratio of ~3.0 (Fig. 3F). The stoichiometry observed in these experiments is in agreement with the result of a recent study (36), and further underscores the specificity of the cytochrome c-tRNA interaction. Influence of the CCA-end of tRNA on cytochrome c binding—We next investigated whether some of the key features of tRNA and cytochrome c regulate their interaction. The addition of the CCA sequence is an essential step in the maturation of tRNA (14,15). To determine whether the CCA sequence is required for cytochrome c binding, we used tRNA species with and without this sequence. An analysis of the interaction between Cy3-htRNA and either bovine or yeast cytochrome c showed no major difference regardless of the presence or absence of the CCA sequence (Table 2). Thus, the CCA sequence does not appear to affect cytochrome c binding. Conversely, we assessed whether cytochrome c influences the CCA addition reaction. Using the human CCA-adding enzyme and under singleturnover conditions, we monitored the A76 addition to the transcript of E. coli tRNA that terminated with C75. Analysis of the time course of the reaction showed that the rate constant of the addition in the presence and absence of cytochrome c was virtually identical (14 vs. 15 s) (Fig. 4A). Thus, the action of the CCA-adding enzyme is not perturbed by cytochrome c. by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 6 We also tested whether CCA-adding enzyme and cytochrome c compete for binding to tRNA. We pre-assembled an etRNA-CCA-adding enzyme complex and performed the binding assay with a range of cytochrome c concentrations. The etRNA in the etRNA-CCA-adding enzyme complex was able to bind cytochrome c with a Kd of 0.9 ± 0.3 μM, essentially the same as the binding of free tRNA with cytochrome c (Kd of 1.0 ± 0.3 μM), determined under the same condition (Fig. 4B). In the crystal structure of a tRNA-CCAadding enzyme complex, the CCA-adding enzyme binds to the top half of the tRNA L shaped tertiary structure near the 3' end (Fig. 4C) (37). Thus, our data indicate that the CCA-adding enzyme does not block the access of cytochrome c to the tRNA structure. Influence of the charging state of tRNA on cytochrome c binding— tRNA charging by cognate aaRS is fundamental to the translation of mRNA into protein. The state of tRNA charging is also an indicator of the nutritional state, and amino acid deprivation leads to rapid accumulation of uncharged tRNAs (14,15). The experiments described above were performed with uncharged tRNA. To assess the influence of the charging state of tRNA, we compared uncharged and charged Cy3-etRNA for binding to cytochrome c. Bovine cytochrome c bound to these two forms of tRNA with similar affinities (Kd = 3.6 ± 0.8 and 3.3 ± 0.7 μM, respectively) (Fig. 4D). Thus, cytochrome c recognizes tRNA independent of its charging state. To evaluate whether cytochrome c competes with aaRS for binding to tRNA, we compared the binding to cytochrome c of free etRNA and etRNA associated with CysRS. The etRNA molecules in these two states bound to cytochrome c with virtually the same affinities (Kd of 1.0 ± 0.3 and 1.2 ± 0.3 μM, respectively) (Fig. 4E). In the crystal structure of etRNA-CysRS complex, the CysRS enzyme binds to the inside of the tRNA L shape (Fig. 4C) (38). The lack of competition between CysRS and cytochrome c is consistent with a model in which cytochrome c binds to the outside corner of the tRNA L shape, hence not in conflict with the binding by CysRS (Fig. 4C). It also suggests that labeling of tRNA at the 5'or 3'end unlikely interferes with its interaction with cytochrome c. Binding of oxidized and reduced cytochrome c to tRNA—Cytochrome c exists in either a reduced or an oxidized form, based on the oxidation state of the iron atom contained within the heme group. The oxidized form is much more potent than the reduced form in the activation of caspases (10). All experiments reported thus far employed oxidized cytochrome c. To test the influence of the redox state of cytochrome c, we compared binding of oxidized and reduced cytochrome c to tRNA directly. Oxidized bovine cytochrome c bound to Cy3-htRNA with a 2-fold weaker affinity compared to the reduced form (Kd = 4.8 ± 0.7 vs. 2.5 ± 1.4 μM) (Fig. 5A, left). Interestingly, removal of the CCA sequence exacerbated the difference in binding between the two states (~ 4fold; Kd = 3.7 ± 0.4 vs. 0.9 ± 0.2 μM) (Fig. 5A, right). We also tested cytochrome c from yeast, which, unlike its vertebrate counterpart, cannot induce caspase activation (39). Oxidized yeast cytochrome c displayed a weaker affinity to Cy3htRNA relative to the reduced form, although this difference was less pronounced than for bovine cytochrome c regardless of the presence or absence of the CCA sequence (Kd = 4.8 ± 0.9 vs. 3.4 ± 0.4 μM in the presence of CCA, and Kd = 7.0 ± 2.0 vs. 3.7 ± 0.7 μM in the absence of CCA) (Fig. 5B). The weaker binding of the oxidized form of mammalian cytochrome c to tRNA correlates with its stronger ability to activate apoptosis. Effect of tRNA binding on the activity of cytochrome c—Cytochrome c possesses peroxidase activity, which promotes the oxidization of cardiolipins early in apoptosis, facilitating the detachment of cytochrome c from cardiolipins and its subsequent release into the cytosol (40). To further investigate how the cytochrome c-tRNA interaction may affect cytochrome c function, we tested whether tRNA binding modulates cytochrome c’s peroxidase activity. In a luminescence assay, tRNA inhibited the peroxidase activity of cytochrome c in a dosedependent manner (Fig. 6A). This finding raises the possibility that tRNA, if present in the intermembrane space upon MOMP, might impede the by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 7 oxidation of cardiolipins and regulate apoptosis at the level of cytochrome c release. tRNA binding facilitates cytochrome c reduction— RNA is extensively oxidized during apoptosis (41). To test whether cytochrome c is capable of directly oxidizing tRNA, we incubated cytochrome c with tRNA and observed the changes in absorbance at 550 nM, which monitors the reduced state. In the absence of tRNA, oxidized cytochrome c was stable for days. However, upon incubation with tRNA, the oxidized-state was gradually converted to the reduced-state, as indicated by the increase in the absorption at 550 nM (Fig. 6B). This increase was dependent on the concentration of tRNA (Fig. 6B). Importantly, pre-digestion of tRNA by addition of the nuclease Onconase (Ranpirnase) prevented cytochrome c reduction (Fig. 6C). These results suggest that tRNA, but not free NMPs, may serve as a substrate for oxidation by cytochrome c. DISCUSSION Discovered by David Keilin and his colleagues in 1920s as one of the color proteins involved in the respiratory chain (42,43), cytochrome c has an essential and evolutionarily conserved role in supporting aerobic eukaryotic life. More than seventy years later, a completely unanticipated role of cytochrome c in vertebrate cell death came to light, when Xiaodong Wang and his colleagues investigated the mechanism of caspase activation (2). The dichotomy of the dual roles of cytochrome c mechanistically links cell life and death, and is fundamental to the evolutionary covenant required for multi-cellular life.. Thus, virtually all vertebrate cells, by depending on cytochrome c for survival, carry this suicide pill for use when and where needed. tRNA is even more evolutionarily ancient and fundamental to life (14,15). Its function as the adaptor molecule in protein synthesis is based on the L-shaped tertiary structure that simultaneously recognizes a genetic codon and an amino acid. This tertiary structure allows for tRNA to interact with both general enzymes, such as the CCAadding enzyme for 3'-end maturation, and specific enzymes, such as aaRS for charging. The Lshaped tertiary structure also affords tRNA nonconventional roles in cells, including priming reverse transcription (16) and, for uncharged tRNA, sensing nutrient deprivation (17). The identification of the association between cytochrome c and tRNA revealed a previously unrecognized connection between two fundamental molecules in life and signified novel biochemical properties of each (13). The findings presented here show that cytochrome c binds to tRNA with an affinity comparable to other tRNAbinding proteins (Fig. 2 and Table 1). Interestingly, cytochrome c binds tRNA without sequence specificity, a property unlike aaRS and more similar to CCA-adding enzyme. Cytochrome c likely recognizes features of the tertiary structure of tRNA, particularly in the core region. The binding stoichiometry of three cytochrome c molecules to a single tRNA molecule (Fig. 3) additionally suggests that multiple cytochrome c molecules are coordinated to recognize a single tRNA. Interestingly, cytochrome c does not compete with either aaRS or CCA-adding enzyme. This could be accounted for in a model in which three cytochrome c molecules bind to the outside corner of the tRNA L shape in a way that does not interfere with the binding of aaRS to the inside of the L structure or with the binding of CCA-adding enzyme to the outside of the L near the 3'-end (Fig. 4C). In cells, tRNAs are extensively modified. These modifications can modulate the structure, function, and stability of tRNAs (15). The tRNA used in this study lack the post-transcriptional modifications. Nevertheless, our data suggest that cytochrome c binds to the outside corner of the tRNA tertiary core, which is not extensively modified relative to the anticodon loop region. Post-transcriptional modifications to the outside corner of the tRNA tertiary core primarily consist of dihydrouridine residues, which have also been used extensively to introduce fluorophores to monitor tRNA dynamics on the ribosome (21,22). This indicates that these residues themselves are not critical for the intra-molecular folding of the tRNA tertiary core. Therefore, we suggest that the use of unmodified tRNAs does not affect the binding with cytochrome c. Apoptosis is tightly regulated at many levels (44,45). The inhibition of the cytochrome c-Apaf1 binding by tRNA may present an important cytosolic regulatory mechanism. Thus, cytosolic tRNAs can bind to cytochrome c that is released by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 8 into the cytoplasm, providing an inhibitory mechanism for apoptosis and linking cellular sensitivity to apoptotic stimuli with the state of protein synthesis (46-48). The current study provides additional insights into the mechanism by which the apoptotic activity of cytochrome c is regulated. Oxidation of cytochrome c stimulates its apoptotic activity, while reduction of cytochrome c inhibits it (10). In apoptotic cells, cytochrome c released into the cytosol is likely maintained in the oxidized form by mitochondrial cytochrome c oxidase, which can act on cytochrome c due to the permeability of the mitochondrial outer membrane (10). By contrast, in cases where the release of cytochrome c fails to induce apoptosis, cytochrome c may be held in the reduced form by reduced glutathione (49). Our observation that tRNA binds to oxidized cytochrome c with a weaker affinity than to reduced cytochrome c (Fig. 5) provides a possible explanation for the different apoptotic activity of these two forms of cytochrome c. tRNA can also convert cytochrome c from the oxidized to the reduced form (Fig. 5). The most likely explanation is that tRNA ribonucleotides contact with the heme group of cytochrome c and donate an electron to the ferric ion (Fe). This likely contributes to the reduction of the apoptotic activity of cytochrome c. The same redox reaction can also blunt the measured peroxidase activity of cytochrome c (Fig. 6). Because the peroxidase activity of cytochrome c is involved in the oxidation of cardiolipids and subsequent release of cytochrome c from the crista space (the space created by the invaginations of the inner membrane) to the cytosol (40), tRNA might also inhibit this function of cytochrome c if it has access to cardiolipids-bound cytochrome c. This scenario seems possible because of the permeability of mitochondrial outer membrane and the remodeling of the crista space during apoptosis. Thus, the redox reaction between cytochrome c and tRNA suggests a broad function by which tRNA impairs the pro-apoptotic activity of cytochrome c, beyond the disruption of cytochrome c-Apaf-1 interaction. On the other hand, cytochrome c-mediated oxidation could cause damage to tRNA and thus may impair translation, further promoting cell death. In addition to representing new modes of regulation and function of cytochrome c in apoptosis, the discovery of the cytochrome ctRNA interaction revealed a theretofore completely unanticipated role of tRNA. Although it had been appreciated that the three-dimensional structure of tRNA endows it with functions beyond gene expression, a direct function in cell fate decision is especially notable. The inhibitory role of tRNA in apoptosis may raise the threshold of apoptosis in cells that are highly active in protein synthesis, a sensible mechanism given the likely utility of these cells to the organism. A recent study showed that tRNA halves, which are generated by endonucleolytic cleavage in the anticodon loop in response to oxidative and other stresses (50), bind to cytochrome c and confer resistance to apoptosis (51). We have shown that a pair of tRNA halves, separated by a nick in the anticodon loop, can nonetheless retain the L-shape structure (26), which may account for their ability to bind to tRNA. Such tRNA halves represent an intriguing example whereby tRNAmediated apoptotic inhibition is regulated physiologically. This mechanism may also be usurped under pathological conditions including cancer. Mammalian cytoplasmic tRNAs are transcribed by RNA polymerase III, which is inhibited by the tumor suppressors p53 and Rb and activated by oncogenes including c-Myc and Ras (52). Mutations in these tumor suppressors/oncogenes cause tRNA levels to rise in tumor cells, and high tRNA levels are required for proliferation and tumorigenesis (52). A better understanding of the molecular interaction between cytochrome c and tRNA and the regulation of this interaction should reveal evolutionarily conserved mechanisms that govern apoptosis, metabolism, and translation, and the consequences of their deregulation in human diseases. ACKNOWLEDGMENTS We thank S. Seeholzer and H. Ding at the Children’s Hospital of Philadelphia’s Protein Core Facility for help with the surface plasmon resonance assay, K. Shogen and W. Ardelt for providing Onconase, W. Prall and N. Charan for technical assistance, and members of the Hou and Yang laboratories for helpful by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 9 discussions. This work was supported in part by National Institutes of Health grants R01 GM081601 and R01 GM108972 (to YMH), R01 GM060911, and R21 CA178581, and the U.S. Department of Defense grant W81XWH-13-1-0446 (to XY). CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest with the contents of this article. AUTHOR CONTRIBUTIONS YMH and XY conceived and coordinated the study and wrote the paper. CL designed, performed, and analyzed the experiments shown in Figures 2B, 2C, 3E, 3F, and 4. AJS designed, performed, and analyzed the experiments shown in Figure 3, A-D, and Figure 5. CL and AJS helped with manuscript preparation. TC designed, performed, and analyzed the experiments shown in Figures 2A, 2D, 4B, and 4E. JY provided advice and technical assistance. RT performed the tRNA-cyt c structural modeling in Figure 4C. The abbreviations used are: aaRS, aminoacyl-tRNA synthetases; Apaf-1, apoptotic protease activating factor-1; Cy3-etRNA, etRNA labeled with Cy3 at the 5'; CysRS, cysteinyl-tRNA synthetase; ECL, enhanced chemilluminescence; etRNA, E. coli tRNA; etRNA, E. coli tRNA; htRNA, human tRNA; htRNA, human elongator tRNA; nt, nucleotide; Prf, proflavine; Prf-etRNA, etRNA labeled with proflavine at the D-loop. REFERENCES 1. Ow, Y. P., Green, D. R., Hao, Z., and Mak, T. W. (2008) Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9, 532-542 2. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157 3. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase3. Cell 90, 405-413 4. Schafer, Z. T., and Kornbluth, S. (2006) The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 10, 549-561 5. Riedl, S. J., and Salvesen, G. S. (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8, 405-413 6. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 7. Chang, H. Y., and Yang, X. (2000) Proteases for Cell Suicide: Functions and Regulation of Caspases. Microbiol Mol Biol Rev 64, 821-846 8. Li, J., and Yuan, J. (2008) Caspases in apoptosis and beyond. Oncogene 27, 6194-6206 9. Riedl, S. J., and Shi, Y. (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5, 897-907 10. Borutaite, V., and Brown, G. C. (2007) Mitochondrial regulation of caspase activation by cytochrome oxidase and tetramethylphenylenediamine via cytosolic cytochrome c redox state. J Biol Chem 282, 31124-31130 11. Jiang, X., Kim, H. E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S. C., Rosenberg, S., and Wang, X. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299, 223-226 12. Kim, H. E., Jiang, X., Du, F., and Wang, X. (2008) PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1. Mol Cell 30, 239-247 by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 10 13. Mei, Y., Yong, J., Liu, H., Shi, Y., Meinkoth, J., Dreyfuss, G., and Yang, X. (2010) tRNA binds to cytochrome c and inhibits caspase activation. Mol Cell 37, 668-678 14. Giege, R. (2008) Toward a more complete view of tRNA biology. Nat Struct Mol Biol 15, 10071014 15. Phizicky, E. M., and Hopper, A. K. (2010) tRNA biology charges to the front. Genes Dev 24, 1832-1860 16. Mak, J., and Kleiman, L. (1997) Primer tRNAs for reverse transcription. J Virol 71, 8087-8095 17. Wek, R. C., Jackson, B. M., and Hinnebusch, A. G. (1989) Juxtaposition of domains homologous to protein kinases and histidyl-tRNA synthetases in GCN2 protein suggests a mechanism for coupling GCN4 expression to amino acid availability. Proc Natl Acad Sci U S A 86, 4579-4583 18. Hou, Y. M., Westhof, E., and Giege, R. (1993) An unusual RNA tertiary interaction has a role for the specific aminoacylation of a transfer RNA. Proc Natl Acad Sci U S A 90, 6776-6780 19. Hou, Y. M. (1994) Structural elements that contribute to an unusual tertiary interaction in a transfer RNA. Biochemistry 33, 4677-4681 20. Nissen, P., Thirup, S., Kjeldgaard, M., and Nyborg, J. (1999) The crystal structure of CystRNACys-EF-Tu-GDPNP reveals general and specific features in the ternary complex and in tRNA. Structure 7, 143-156 21. Liu, C., Betteridge, T., and Hou, Y. M. (2009) Fluorophore labeling to monitor tRNA dynamics. Methods in Enzymology 469, 69-93 22. Betteridge, T., Liu, H., Gamper, H., Kirillov, S., Cooperman, B. S., and Hou, Y. M. (2007) Fluorescent labeling of tRNAs for dynamics experiments. RNA 13, 1594-1601 23. Hauenstein, S. I., Hou, Y. M., and Perona, J. J. (2008) The homotetrameric phosphoseryl-tRNA synthetase from Methanosarcina mazei exhibits half-of-the-sites activity. J Biol Chem 283, 21997-22006 24. Igarashi, T., Liu, C., Morinaga, H., Kim, S., and Hou, Y. M. (2011) Pyrophosphorolysis of CCA addition: implication for fidelity. J Mol Biol 414, 28-43 25. Kim, S., Liu, C., Halkidis, K., Gamper, H. B., and Hou, Y. M. (2009) Distinct kinetic determinants for the stepwise CCA addition to tRNA. RNA 15, 1827-1836 26. Dupasquier, M., Kim, S., Halkidis, K., Gamper, H., and Hou, Y. M. (2008) tRNA integrity is a prerequisite for rapid CCA addition: implication for quality control. J Mol Biol 379, 579-588 27. Liu, C., Gamper, H., Liu, H., Cooperman, B. S., and Hou, Y. M. (2011) Potential for interdependent development of tRNA determinants for aminoacylation and ribosome decoding. Nat Commun 2, 329 28. Christian, T., Lipman, R. S., Evilia, C., and Hou, Y. M. (2000) Alternative design of a tRNA core for aminoacylation. J Mol Biol 303, 503-514 29. Liu, C., Sanders, J. M., Pascal, J. M., and Hou, Y. M. (2012) Adaptation to tRNA acceptor stem structure by flexible adjustment in the catalytic domain of class I tRNA synthetases. RNA 18, 213-221 30. Zhang, C. M., and Hou, Y. M. (2005) Domain-domain communication for tRNA aminoacylation: the importance of covalent connectivity. Biochemistry 44, 7240-7249 31. Zhang, C. M., Perona, J. J., Ryu, K., Francklyn, C., and Hou, Y. M. (2006) Distinct kinetic mechanisms of the two classes of Aminoacyl-tRNA synthetases. J Mol Biol 361, 300-311 32. Liu, C., Gamper, H., Shtivelband, S., Hauenstein, S., Perona, J. J., and Hou, Y. M. (2007) Kinetic quality control of anticodon recognition by a eukaryotic aminoacyl-tRNA synthetase. J Mol Biol 367, 1063-1078 33. Lee, Y. S., Shibata, Y., Malhotra, A., and Dutta, A. (2009) A novel class of small RNAs: tRNAderived RNA fragments (tRFs). Genes Dev 23, 2639-2649 34. Hamann, C. S., and Hou, Y. M. (2000) Probing a tRNA core that contributes to aminoacylation. J Mol Biol 295, 777-789 35. Hamann, C. S., and Hou, Y. M. (1997) An RNA structural determinant for tRNA recognition. Biochemistry 36, 7967-7972 by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA 11 36. Suryanarayana, T., Uppala, J. K., and Garapati, U. K. (2012) Interaction of cytochrome c with tRNA and other polynucleotides. Mol Biol Rep 39, 9187-9191 37. Yamashita, S., Takeshita, D., and Tomita, K. (2014) Translocation and rotation of tRNA during template-independent RNA polymerization by tRNA nucleotidyltransferase. Structure 22, 315325 38. Hauenstein, S., Zhang, C. M., Hou, Y. M., and Perona, J. J. (2004) Shape-selective RNA recognition by cysteinyl-tRNA synthetase. Nat Struct Mol Biol 11, 1134-1141 39. Yuan, J. (2006) Divergence from a dedicated cellular suicide mechanism: exploring the evolution of cell death. Mol Cell 23, 1-12 40. Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V., Vlasova, II, Zhao, Q., Zou, M., Di, P., Svistunenko, D. A., Kurnikov, I. V., and Borisenko, G. G. (2005) Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1, 223-232 41. Degen, W. G., Pruijn, G. J., Raats, J. M., and van Venrooij, W. J. (2000) Caspase-dependent cleavage of nucleic acids. Cell Death Differ 7, 616-627 42. Keilin, D. (1925) On cytochrome, a respiratory pigment, common to animals, yeast, and higher plants. Proc R Soc Lond B Biol Sci 98, 312-339 43. Slater, E. C. (2003) Keilin, cytochrome, and the respiratory chain. J Biol Chem 278, 16455-16461 44. Jiang, X., and Wang, X. (2004) Cytochrome C-mediated apoptosis. Annu Rev Biochem 73, 87106 45. Tait, S. W., and Green, D. R. (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621-632 46. Mei, Y., Stonestrom, A., Hou, Y. M., and Yang, X. (2010) Apoptotic regulation and tRNA. Protein Cell 1, 795-801 47. Mei, Y., Yong, J., Stonestrom, A., and Yang, X. (2010) tRNA and cytochrome c in cell death and beyond. Cell Cycle 9, 2936-2939 48. Hou, Y. M., and Yang, X. (2013) Regulation of Cell Death by Transfer RNA. Antioxid Redox Signal 49. Vaughn, A. E., and Deshmukh, M. (2008) Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 10, 1477-1483 50. Thompson, D. M., and Parker, R. (2009) Stressing out over tRNA cleavage. Cell 138, 215-219 51. Saikia, M., Jobava, R., Parisien, M., Putnam, A., Krokowski, D., Gao, X. H., Guan, B. J., Yuan, Y., Jankowsky, E., Feng, Z., Hu, G. F., Pusztai-Carey, M., Gorla, M., Sepuri, N. B., Pan, T., and Hatzoglou, M. (2014) Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress. Mol Cell Biol 34, 2450-2463 52. White, R. J. (2005) RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 6, 69-78 by gest on M arch 5, 2016 hp://w w w .jb.org/ D ow nladed from Molecular interaction of cytochrome c and tRNA